ArticleCureus2026
Transforming Breast Cancer Control in East Africa by Integrating Cytomorphology and Genetics Into National Policy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The traditional approach to breast cancer control in Sub-Saharan Africa and East Africa has long been hindered by a reactive healthcare model that prioritizes symptomatic management over early, risk-stratified interventions. Drawing upon a multi-year research program conducted in Kenya that investigated cytomorphological patterns, epidemiological risk factors, and BRCA1/2 mutations, this perspective argues for a fundamental shift in national health policy. We propose that the current siloed diagnostic pathway may not be sufficient for the unique Kenyan and East African breast cancer phenotype, which is characterized by aggressive biology and early-onset presentation. This paper recommends repositioning fine-needle aspiration cytology (FNAC) as a triage tool followed by integration of genetic screening into the primary care framework. With this, East Africa can progressively move from a state of diagnostic delays to a model of precision public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.